Core Viewpoint - The accessibility of innovative drugs and medical devices is crucial for patient health and the pharmaceutical industry's innovation development. Recent measures from Shanghai's financial regulatory authorities aim to enhance the role of commercial health insurance in this sector [1][4]. Group 1: Policy Measures - The Shanghai Financial Regulatory Bureau and seven other departments released 18 specific measures to promote the high-quality development of commercial health insurance, focusing on collaboration between basic medical insurance and commercial insurance [1][5]. - The measures clarify responsibilities among various departments and aim to quickly implement policies that will enhance the multi-layered medical security system [1][4]. Group 2: Market Dynamics - The innovative drug industry in China is experiencing rapid growth, with 43 innovative drugs approved in the first half of 2025, a 59% increase year-on-year [2]. - The current payment system for high-priced drugs shows structural deficiencies, with personal out-of-pocket expenses remaining high due to limited coverage from basic medical insurance [2][3]. Group 3: Role of Commercial Health Insurance - Commercial health insurance is identified as a key player in filling the payment gap for high-priced innovative drugs, providing more predictable payment solutions compared to charity or mutual aid [3][6]. - The growth of commercial health insurance premiums, which reached 622.3 billion yuan in the first half of 2025, indicates a growing market potential [2]. Group 4: Data Sharing and Product Innovation - The measures emphasize the importance of data sharing between medical institutions and insurance companies to enhance pricing accuracy and efficiency [8]. - Encouragement for the development of diverse health insurance products that cover innovative drugs is highlighted, aiming to meet the needs of different demographics [7][8]. Group 5: Future Outlook - The ongoing policy support and product innovation are expected to significantly enhance the role of commercial health insurance in improving the accessibility of innovative drugs [6][8]. - The collaboration between medical, insurance, and pharmaceutical sectors is anticipated to create a win-win situation, fostering a more robust multi-payment system for innovative drugs [6][7].

盛夏时节，在湖州市长兴县的纺织车间里，一台台新上线的节能设备正高速运转，这些设备的背 后，是"转型贷款+ESG保险"创新模式在支撑。作为当地支柱产业，长兴纺织业长期受困于高能耗、高 污染的发展瓶颈，2000余家市场经营主体的转型需求迫切。 据人保财险安吉支公司相关人士介绍，安吉白茶气象指数保险的独特之处在于，其以客观气象数据 为理赔依据，彻底改变了传统农业保险定损难、周期长的痛点。在县政府公布的白茶开采日前10天至开 采后21天内，只要气象站点监测到当日最低气温跌破0.5℃，理赔程序自动触发，实现"精准滴灌"，让 保险真正成为茶农抵御自然风险的"及时雨"。 "以前想更新设备却怕资金链断裂，现在有了保险托底，敢放心投入了。"长兴国圆印染有限公司负 责人邵云舟的感慨道出了众多企业的心声。据介绍，得益于人保财险长兴支公司为该企业投保的6870万 元ESG保险，企业获得信用背书，不仅碳效等级从4级提升至3级，从银行获取的贷款额度也从500万元 增至1000万元，贷款利率还降低了20个基点，让企业在设备更新的关键期获得了"粮草"补充。 2025年，安吉白茶气象指数低温保险累计承保面积8145.6亩，覆盖了全县12个乡镇 ...

新京报贝壳财经讯（记者潘亦纯）针对投资者提出的今年起为何中国平安不再披露每月保费收入数据的 问题，中国平安8月12日在上证e互动平台回复称，切换新准则后，原保险保费收入不能完全反映保险公 司尤其是人身险公司的保险服务收入情况，此项也不是目前监管要求必须披露的信息。保险经营每个季 度都有波动，短期数据对投资者价值不大，公司更注重价值指标，而非规模指标。 Wind数据显示，中国平安最后披露的一份保费收入公告是在2025年1月14日，披露2024年全年的原保险 合同保费收入。 值得一提的是，今年不再披露月保费收入的上市险企并非个例，除了中国平安外，中国人寿、中国人保 也不再披露今年每个月的保费收入数据。不过，另两家上市险企新华保险、中国太保仍披露相关数据。 （文章来源：新京报） ...

证券代码：601628 证券简称：中国人寿 编号：临2025－024 中国人寿保险股份有限公司 关于董事任职资格获金融监管总局核准的公告 重要提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 中国人寿保险股份有限公司（"本公司"）于2024年6月27日召开2023年年度股东大会，选举牛凯龙先生 为本公司第八届董事会非执行董事。 本公司近日收到国家金融监督管理总局（"金融监管总局"）关于牛凯龙任职资格的批复。根据该批复， 金融监管总局已核准牛凯龙先生担任本公司董事的任职资格，其任职自2025年8月6日起生效。自同日 起，牛凯龙先生担任本公司第八届董事会战略与资产负债管理委员会委员。 牛凯龙先生的简历请见本公司于2024年5月22日在上海证券交易所网站（www.sse.com.cn）发布的《中 国人寿保险股份有限公司2023年年度股东大会会议资料》。 特此公告 中国人寿保险股份有限公司 董事会 2025年8月12日 ...

Core Viewpoint - The insurance industry is experiencing a downward adjustment in the preset interest rates for insurance products, with significant implications for investment returns and product structure [1][2]. Group 1: Adjustments in Preset Interest Rates - Several insurance companies have announced reductions in the maximum preset interest rates for newly filed life insurance products, with ordinary insurance products now at 2.0%, participating insurance products at 1.75%, and universal insurance products at a maximum guaranteed rate of 1.0%, reflecting decreases of 50, 25, and 50 basis points respectively [1]. - The preset interest rates for insurance products have undergone multiple adjustments since the introduction of floating yield insurance, leading to a shift in product structure towards "guaranteed returns + floating returns" participating insurance becoming mainstream [1]. Group 2: Investment Returns of Life Insurance Companies - As of now, 58 life insurance companies have disclosed their investment return rates for the first half of 2025, with most institutions reporting rates between 1% and 3%, and some experiencing declines compared to the previous year [2]. - Specific examples include Hengtai Life, which saw its investment return rate drop from 2.67% in the first half of 2024 to 0.96% in the first half of 2025, a decrease of 1.71 percentage points [2]. - Among the companies with investment returns exceeding 3% are Lianan Life (3.22%), Junlong Life (4.67%), Guomin Pension Insurance (3.01%), Xingfu Life (3.08%), and Beijing Life (3.65%) [2]. Group 3: Factors Influencing Negative Investment Returns - Negative investment returns can occur due to the classification of investment assets and trading strategies, particularly if companies use fair value measurement for financial assets and experience significant declines in market value [3]. - Large impairments in debt assets or significant credit losses can also adversely affect current profits, leading to lower investment return rates [3]. Group 4: Evaluating Participating Insurance - The solvency reports from insurance companies reveal both investment return rates and comprehensive investment return rates, with the latter generally being higher [4]. - For instance, Changcheng Life reported an investment return rate of 2.58% alongside a comprehensive investment return rate of 6.82% for the first half of 2025 [4]. - Comprehensive investment return rates reflect a broader view of investment performance, including unrealized gains and losses, making them more representative of an insurance company's overall investment capability [5]. Group 5: Consumer Considerations - Consumers are advised to focus on long-term comprehensive investment return rates when selecting participating insurance products, considering historical performance and dividend realization rates [5].

Group 1: Personal Consumption Loan Subsidy Policy - The Ministry of Finance, People's Bank of China, and Financial Regulatory Bureau issued a subsidy policy for personal consumption loans from September 1, 2025, to August 31, 2026 [1] - The subsidy applies to personal consumption loans used for specific categories such as household vehicles, education, and health care, with a maximum subsidy of 1% per year, not exceeding 50% of the loan contract interest rate [1] - The central and provincial finances will bear 90% and 10% of the subsidy costs, respectively [1] Group 2: Service Industry Loan Subsidy Policy - Nine departments, including the Ministry of Finance, released a subsidy policy for loans to service industry entities in eight sectors, including dining, health, and tourism [2] - The subsidy is capped at 1% per year for a maximum loan amount of 1 million yuan, with the same cost-sharing structure as the personal consumption loan policy [2] - Loan funds must be used for compliant business activities and cannot be diverted for real estate or investment purposes [2] Group 3: Medical Insurance and Commercial Insurance Drug Directory Adjustments - The National Medical Insurance Administration is conducting a preliminary review of drug applications for the 2025 drug directory adjustments [3] - Feedback will be collected during the public review period to finalize the list of drugs that pass the initial review [3] - The process will include expert evaluations and price negotiations for the basic medical insurance directory [3] Group 4: Import Tariff Adjustments on U.S. Goods - The State Council announced adjustments to tariffs on U.S. imports, maintaining a 10% tariff while suspending a 24% tariff for 90 days [5] - This decision aligns with the outcomes of U.S.-China trade talks and is based on relevant laws and international principles [5] Group 5: Agricultural Product Import Tariff Quota Redistribution - The National Development and Reform Commission and the Ministry of Commerce outlined the redistribution of import tariff quotas for agricultural products [9] - Users holding quotas must return any unutilized portions by September 15, with penalties for non-compliance affecting future quota allocations [9] Group 6: New Business Entity Registrations - The State Administration for Market Regulation reported over 13.27 million new business entities registered in the first half of the year, with a notable increase in private and foreign enterprises [12] - The growth reflects a stable trend across various ownership types and sectors, particularly in the service industry [12] - The "Four New" economy enterprises reached 25.36 million, accounting for 40.2% of total enterprises, indicating a shift towards new technologies and business models [12]

Group 1: Financial Support for Innovation - The plan aims to promote financial institutions in Nansha to innovate bill discount products and increase bill financing support under legal and risk-controlled conditions [1] - It emphasizes the development of intellectual property financial services and encourages the establishment of private equity investment funds by domestic insurance institutions in Nansha [1] Group 2: Digital Industry Development - The plan highlights the importance of attracting key digital service institutions such as blockchain and artificial intelligence, and fostering local quality digital service providers [2] - It supports the establishment of data computing centers and regulatory platforms for the integration of key digital technologies with financial applications in Nansha [2] Group 3: Marine and Future Industry Development - The plan supports equity investment funds in the marine high-tech industry and enhances financial services for major marine infrastructure projects [2] - It aims to increase marine insurance supply and promote innovation in traditional marine insurance products [2] Group 4: Youth Innovation and Entrepreneurship - The plan encourages commercial banks in Nansha to enhance service convenience and establish green channels for Hong Kong and Macau residents to facilitate banking services for entrepreneurial youth [2]

Core Points - The China Banking and Insurance Regulatory Commission (CBIRC) is committed to enhancing financial support for the manufacturing sector, aligning with the decisions of the Central Committee and the State Council [1][2] - A notification was issued outlining 12 measures to improve financial services for manufacturing, emphasizing the need for banks and insurance institutions to increase their support [1] - Financial product innovation is encouraged to meet the specific needs of manufacturing enterprises, focusing on differentiated and comprehensive services [1] - There is a push to optimize the credit structure, with an emphasis on increasing medium- and long-term loans to advanced manufacturing and strategic emerging industries [1][2] - Continued financial support for industries affected by the pandemic is prioritized, with a focus on small and micro enterprises [1] - The regulatory body aims to enhance the incentive mechanisms for banks and insurance institutions to promote lending to manufacturing enterprises [1] Financial Data - By the end of 2021, loans to the manufacturing sector increased by 2.8 trillion yuan, with medium- and long-term loans rising by 2.1 trillion yuan and credit loans by 1.1 trillion yuan [2] - High-tech manufacturing loans saw an increase of 580.7 billion yuan [2]

在中国人民大学中国普惠金融研究院昨日举办的"从数字化农业保险到绿色乡村振兴——绿色农业 保险专题研讨会"上，原中国保监会副主席周延礼表示，要持续发挥保险保障作用，多角度、多措施、 多层次地助力乡村振兴。 周延礼表示，保险公司应充分利用信息科技、网络化、智能化和数字化能力，通过运用大数据、云 计算、卫星遥感、无人机、远程查勘等技术手段，健全精准高效的查勘定损机制，提升保险理赔效率， 为智慧农业、数字农业发展保驾护航。 由于缺乏合适的抵押品、信用体系不健全，农户长期面临贷款难题。周延礼表示，应积极探索"保 险+银行+政府"的多方信贷风险分担补偿机制，通过小额贷款保证保险试点拓宽保险增信途径，低成本 盘活农户资产，缓解农户贷款难、贷款贵等问题。 同时，对于农民自身而言，保险业还应重点对农村居民的健康险业务、定期寿险业务、意外险业务 做出探索。"可以给贫困人口提供住房风险保障，对农村低保户、五保户家庭人员和农村孤儿提供'两保 一孤'大病补充保险，推动保险资金到西部地区去。" 周延礼表示。 周延礼认为，还应该利用保险手段防止脱贫人口因病、因学返贫。尤其是一些老少边穷地区，应该 利用保险手段巩固脱贫成果。不断改革创新，理 ...

Core Viewpoint - The rapid growth of the new energy vehicle (NEV) industry in China has led to increased consumer acceptance, creating significant market potential for dedicated NEV insurance products [1][2]. Group 1: Market Acceptance and Development - The dedicated NEV insurance was officially launched on December 27, 2021, following the release of specific insurance clauses by the China Insurance Industry Association [1]. - The acceptance of NEV insurance among consumers has been high, with many customers reporting that it has effectively addressed their practical issues [1][2]. - As of the end of 2021, the number of NEVs in China reached 7.84 million, with projections indicating that by 2025, NEV sales will account for approximately 20% of total new car sales [2][3]. Group 2: Insurance Premiums and Adjustments - According to a report from招商证券, 20.7% of vehicles have seen an increase in base premium rates, while others remain stable or have decreased [3]. - Some NEV owners have expressed concerns about premium increases despite lower vehicle prices compared to traditional fuel vehicles [3][4]. - The insurance industry is still in the early stages of developing NEV insurance, with ongoing data accumulation and optimization of premium calculation models [3][4]. Group 3: Future Outlook and Innovations - The introduction of NEV insurance is viewed as an innovation within the property insurance sector, with companies aiming to enhance service quality and product offerings [5]. - The growth in NEV ownership is expected to create a positive feedback loop, leading to more policies and further market expansion for NEV insurance [5].